Literature DB >> 17266026

Dynamic stromal-epithelial interactions during progression of MCF10DCIS.com xenografts.

Larry R Tait1, Robert J Pauley, Steven J Santner, Gloria H Heppner, Henry H Heng, Janusz W Rak, Fred R Miller.   

Abstract

MCF10DCIS.com cells form comedo type ductal carcinoma in situ in immune-deficient mice before forming invasive ductal carcinoma. As the lesions mature, both stromal and epithelial cells undergo phenotypic changes detected by immunohistochemistry. Myofibroblasts are present before the formation of carcinoma in situ and after development of invasive carcinoma. MCF10DCIS. com lesions develop a myoepithelial layer prior to exhibiting a basement membrane surrounding the ductal mass. TGFbeta1 is initially expressed by the epithelial cells but is expressed by stroma in invasive carcinoma. Stromal derived factor-1 is detected in epithelial cells in early carcinoma in situ but is produced in stromal cells in invasive carcinoma. The receptor CXCR4 is expressed by epithelial cells in the xenografts at all times, as is the hepatocyte growth factor receptor c-met. MCF10DCIS.com xenografts illustrate the dynamic interplay of epithelium and stroma in the development of carcinoma in situ and subsequent invasive carcinoma. Although the phenotype of the epithelial cells may be dependent upon the stroma, the malignant epithelium induces the development of the stroma necessary for progression to the invasive stage. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17266026     DOI: 10.1002/ijc.22572

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  42 in total

Review 1.  Intra-mammary ductal transplantation: a tool to study premalignant progression.

Authors:  Daniel Medina; David G Edwards; Frances Kittrell; Sangjun Lee; D Craig Allred
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-06-12       Impact factor: 2.673

2.  Transforming growth factor beta1 enhances tumor promotion in mouse skin carcinogenesis.

Authors:  Rolando Pérez-Lorenzo; Lauren Mordasky Markell; Kelly A Hogan; Stuart H Yuspa; Adam B Glick
Journal:  Carcinogenesis       Date:  2010-02-19       Impact factor: 4.944

3.  Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts.

Authors:  Yasushi Kojima; Ahmet Acar; Elinor Ng Eaton; Kieran T Mellody; Christina Scheel; Ittai Ben-Porath; Tamer T Onder; Zhigang C Wang; Andrea L Richardson; Robert A Weinberg; Akira Orimo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

Review 4.  Targeting the tumour stroma to improve cancer therapy.

Authors:  Kenneth C Valkenburg; Amber E de Groot; Kenneth J Pienta
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

Review 5.  Insidious changes in stromal matrix fuel cancer progression.

Authors:  Fayth L Miles; Robert A Sikes
Journal:  Mol Cancer Res       Date:  2014-01-22       Impact factor: 5.852

6.  Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases.

Authors:  Pratima Nangia-Makker; Tirza Raz; Larry Tait; Malathy P V Shekhar; Hong Li; Vitaly Balan; Hemanckur Makker; Rafael Fridman; Krishnarao Maddipati; Avraham Raz
Journal:  Cancer Biol Ther       Date:  2013-02-04       Impact factor: 4.742

7.  Differential Expression of Key Signaling Proteins in MCF10 Cell Lines, a Human Breast Cancer Progression Model.

Authors:  Jae Young So; Hong Jin Lee; Pavel Kramata; Audrey Minden; Nanjoo Suh
Journal:  Mol Cell Pharmacol       Date:  2012-01-01

8.  A model of postsurgical advanced metastatic breast cancer more accurately replicates the clinical efficacy of antiangiogenic drugs.

Authors:  Eric Guerin; Shan Man; Ping Xu; Robert S Kerbel
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

9.  SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium.

Authors:  Rebecca Marlow; Phyllis Strickland; Ji Shin Lee; Xinyan Wu; Milana Pebenito; Mikhail Binnewies; Elizabeth K Le; Angel Moran; Hector Macias; Robert D Cardiff; Saraswati Sukumar; Lindsay Hinck
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

Review 10.  Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression.

Authors:  Masayuki Shimoda; Kieran T Mellody; Akira Orimo
Journal:  Semin Cell Dev Biol       Date:  2009-10-24       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.